The MB gains a toxic function, rather than loses a protective function, in response to HS in the absence of dPGAM5. by Yosuke Ishida (185168)

“…(<b>D</b>) Suppression of neurotransmission does not decrease vulnerability of <i>PGAM5¹</i> flies to HS. …”

Data_Sheet_5_Modulation of Microglial Activation by Adenosine A2a Receptor in Animal Models of Perinatal Brain Injury.pdf by Marina Colella (5735873)

Fig 5 - by Min Wu (41570)

Map showing age-standardized rates of incidence (A), deaths (C) and Disability-adjusted life years (DALYs) (E) in 2021 and average annual percent change of incidence (B), deaths (D... by Mengjia Zhu (15469202)

Map showing age-standardized rates of incidence (A), deaths (C) and Disability-adjusted life years (DALYs) (E) in 2021 and average annual percent change of incidence (B), deaths (D... by Mengjia Zhu (15469202)

Map showing age-standardized rates of incidence (A), deaths (C) and Disability-adjusted life years (DALYs) (E) in 2021 and average annual percent change of incidence (B), deaths (D... by Mengjia Zhu (15469202)

Map showing age-standardized rates of incidence (A), deaths (C) and Disability-adjusted life years (DALYs) (E) in 2021 and average annual percent change of incidence (B), deaths (D... by Mengjia Zhu (15469202)

Map showing age-standardized rates of incidence (A), deaths (C) and Disability-adjusted life years (DALYs) (E) in 2021 and average annual percent change of incidence (B), deaths (D... by Mengjia Zhu (15469202)

Fig 5 - by Hsun Chiang (19193901)

Fig 5 - by Christophe Verbist (6104075)

Fig 5 - by Je Moon Woo (9454911)

“…The right eye of a patient with NTG, showing a mean deviation (HVF) of −5.41 dB. …”

Scatterplot 5. by Chao Yang (174810)

Fig 5 - by Yanchun Zhang (556475)

Fig 5 - by Adam Lampert (413952)

“…<p>The annual cost of treatment decreases with the target speed <i>v</i> and increases with <i>kλ</i>_<i>0</i> (spongy moth population model). …”

Fig 5 - by Suzan Farhang-Sardroodi (4622056)

“…<p>Parameter sensitivity analysis for parameter <i>R</i>_<i>d</i> using a 35 mg/kg daily (Left: A, B, C) or 49 mg/kg (5-on, 2-off) (Right: D, E, F) chemotherapy schedule to deliver a 245 mg/kg weekly dose. …”

Fig 5 - by Melinda Liu Perkins (6116204)

“…Right, changing the diffusion ratio shifts the nullcline for front velocity toward lower concentrations of the faster-diffusing species. Decreasing the diffusivity also decreases the width (increases the steepness) of the respective front (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1008589#pcbi.1008589.s004" target="_blank">S2 Appendix</a>).…”

Figure 5 by Madeleine Moule (17783918)

“…<p dir="ltr">Figure 5: Cytotoxicity of Peptoid TM5 in three-dimensional models of the human lung A549 cells were treated with peptoid for 3 hours, then analyzed by MTT assay. …”

Fig 5 - by Md Ehtashamul Haque (13020918)

“…All recordings are available from (S2 Fig in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0266769#pone.0266769.s001" target="_blank">S1 File</a>) <b>(B)</b> Critical speed measurement in Ansys workbench <b>B.i)</b> Meshing of Design C (Nodes: 6749, Elements: 39228) C <b>B.ii)</b> Mode shape during natural frequency <b>B.iii)</b> Simulated (model) vs experimental critical speed of each conical shape design showing a good agreement between them with low percentage difference (1–5%) <b>(C)</b> Measured deflection of each conical shape design showing all designs experiencing deflection from 4 to 7 mm <b>(D)</b> Duration of deflection higher than 1.5 mm was decreasing the lowering of critical speed except design E5 which experienced higher deflection for longer times.…”

Fig 5 - by Amber D. Fandel (5831456)

Fig 5 - by Jessica N. Sanchez (8856284)

“…As the percentage of vaccinated foxes increased, the probability of epidemic fadeout (A, B) generally remained stable and the percentage of foxes infected (i.e. latent, infectious, or dead) by the end of the 365-day simulation (C, D) generally decreased.…”